SynthesisFrontiers in neurology
A systematic review of non-invasive biomarkers for seizure forecasting in pediatric epilepsy patients.
Synthesis in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epilepsy is one of the most common neurological disorders globally. While medications, surgical interventions, and dietary changes can be successful in controlling seizures, a subset of individuals experience refractory epilepsy and are at increased risk for sudden unexpected death in epilepsy (SUDEP). Efforts to provide a detection system using devices have been successful at identifying seizures once they start, but there are no devices or systems on the market that predict seizures. The purpose of this systematic review (PROSPERO ID: CRD42024444250) is to determine non-invasive physiologic and environmental biomarkers that can be used to forecast seizures in pediatric epilepsy patients. Methods: A systematic search of relevant literature was conducted in PubMed, Web of Science, CINAHL Ultimate, and EMBASE in August 2023. Articles were reviewed by two investigators in a two-step process. Data extraction occurred using two independent extractors to identify study characteristics, patient characteristics, and forecasting results. Evidence quality was evaluated by two investigators using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool. Results: Eleven observational cohort studies were included and cardiovascular biomarkers using electrocardiogram (ECG) measurement were most commonly used. Pre-ictal anticipation algorithm times ranged from 21.8 s to 32 min, while correlational studies observed cardiovascular biomarker changes 3.59 s to 40 min before seizures. This systematic review provides a comprehensive overview of the current evidence for seizure forecasting. However, the evidence in 9/11 of reviewed studies were rated as either low or very low certainty using the GRADE tool due to methodological flaws, risk of bias, inconsistent results, and indirect or sparse evidence. Discussion: There are ongoing opportunities to build on our findings, including further testing of cardiovascular biomarkers with other physiologic and environmental factors, larger sample size studies, and a precision medicine approach to tailoring algorithms and biomarker measurements to individual patients. Systematic review registration: PROSPERO (ID: CRD42024444250).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.